| 553 An HIV/AIDS vaccine: where do we go from here? EM Campbell, TJ Hope, TI de Silva, M Cotten, SL Rowland-Jones, ... | | |
| 8.4 Paper 4-Examination of Influenza Specific T-Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+ M1 Vaccine TJ Powell, Y Peng, TK Berthoud, ME Blais, PJ Lillie, AVS Hill, ... Influenza vaccinology and clinical assessment, 107, 2014 | | 2014 |
| 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19â 22 July 2015, Vancouver, Canada KM Pate, C Pohlmeyer, V Walker‐Sperling, J Foote, K Najarro, C Cryer, ... International AIDS Society, 2015 | | 2015 |
| A 2 Amino Acid Shift in Position Leads to a Substantial Difference in the Pattern of Processing of 2 HIV-1 Epitopes A Culshaw, T Dong, SL Rowland-Jones JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (4), 335-339, 2012 | 5 | 2012 |
| A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa GS Gottlieb, SP Eholié, JN Nkengasong, S Jallow, S Rowland-Jones, ... Aids 22 (16), 2069-2072, 2008 | 113 | 2008 |
| A commentary on the interagency symposium:‘Building a healthier future: a human capital perspective on health and education’, presented at the European Congress of Tropical … D Bundy, C Burbano, E Lloyd-Evans, G Sorgho, F Lavadenz, Z Adam, ... International health 12 (4), 235-237, 2020 | 5 | 2020 |
| A common frame of reference for learned and communicated vectors in honeybee navigation R Menzel, A Kirbach, WD Haass, B Fischer, J Fuchs, M Koblofsky, ... Current Biology 21 (8), 645-650, 2011 | 144 | 2011 |
| A comprehensive analysis of the impact of HIV on HCV immune responses and its association with liver disease progression in a unique plasma donor cohort YH Zhang, Y Zhao, US Rajapaksa, TM Lawrence, YC Peng, J Liu, K Xu, ... Plos one 11 (7), e0158037, 2016 | 3 | 2016 |
| A comprehensive analysis of the impact of HIV on HCV immune responses and its association with liver disease progression in a unique plasma donor cohort. ZYH Zhang YongHong, ZY Zhao Yan, US Rajapaksa, TM Lawrence, ... | | 2016 |
| A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara … M Mwau, I Cebere, J Sutton, P Chikoti, N Winstone, EGT Wee, T Beattie, ... Journal of general virology 85 (4), 911-919, 2004 | 261 | 2004 |
| A new variant of killer-cell immunoglobulin-like receptor KIR3DL1* 03101 isolated using sequence-based techniques. LM Yindom, G Wong, TI de Silva, SL Rowland‐Jones Tissue antigens 84 (5), 2014 | | 2014 |
| A novel full length KIR3DL1* 0070103 identified by molecular typing. LM Yindom, L Wang, SL Rowland‐Jones, T Dong Tissue antigens 82 (6), 2013 | | 2013 |
| A novel full-length KIR3DS1* 0130106 allele identified by sequencing. L Wang, YH Zhang, T Dong, SL Rowland‐Jones, LM Yindom Tissue antigens 83 (5), 2014 | | 2014 |
| A novel full-length two-domain KIR2DL5A allele isolated in Zimbabwean samples: KIR2DL5A* 0010104. L van Pul, E Majonga, R Ferrand, SL Rowland-Jones, LM Yindom HLA: Immune Response Genetics 96 (1), 135-136, 2020 | 2 | 2020 |
| A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais S Buranapraditkun, U Hempel, P Pitakpolrat, RL Allgaier, P Thantivorasit, ... PLoS One 6 (8), e23603, 2011 | 18 | 2011 |
| A novel KIR 3 DS 1* 0130107 allele isolated by sequencing from an A sian donor LM Yindom, L Wang, K Xu, T Dong, SL Rowland‐Jones International journal of immunogenetics 41 (3), 267-268, 2014 | | 2014 |
| A novel KIR3DL1* 0070104 allele found in individuals from Asia. LM Yindom, L Wang, T Dong, SL Rowland‐Jones Tissue antigens 83 (3), 2014 | | 2014 |
| A novel KIR3DL1* 0150103 subtype identified in West Africa. LM Yindom, K James, TI de Silva, SL Rowland‐Jones Tissue Antigens 86 (1), 2015 | | 2015 |
| A novel KIR3DL1* 0200102 allele isolated from a West African donor by sequence-based typing. LM Yindom, TI de Silva, SL Rowland‐Jones Tissue antigens 83 (4), 2014 | 2 | 2014 |
| A phase I randomized clinical trial of candidate human immunodeficiency virus type 1 vaccine MVA. HIVA administered to Gambian infants MO Afolabi, J Ndure, A Drammeh, F Darboe, SR Mehedi, ... PloS one 8 (10), e78289, 2013 | 25 | 2013 |
